1. Home
  2. RGNX vs DDL Comparison

RGNX vs DDL Comparison

Compare RGNX & DDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGNX
  • DDL
  • Stock Information
  • Founded
  • RGNX 2008
  • DDL 2014
  • Country
  • RGNX United States
  • DDL China
  • Employees
  • RGNX N/A
  • DDL N/A
  • Industry
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • DDL Catalog/Specialty Distribution
  • Sector
  • RGNX Health Care
  • DDL Consumer Discretionary
  • Exchange
  • RGNX Nasdaq
  • DDL Nasdaq
  • Market Cap
  • RGNX 424.8M
  • DDL 457.4M
  • IPO Year
  • RGNX 2015
  • DDL 2021
  • Fundamental
  • Price
  • RGNX $8.70
  • DDL $2.22
  • Analyst Decision
  • RGNX Strong Buy
  • DDL
  • Analyst Count
  • RGNX 8
  • DDL 0
  • Target Price
  • RGNX $31.75
  • DDL N/A
  • AVG Volume (30 Days)
  • RGNX 788.1K
  • DDL 413.7K
  • Earning Date
  • RGNX 07-31-2025
  • DDL 08-06-2025
  • Dividend Yield
  • RGNX N/A
  • DDL N/A
  • EPS Growth
  • RGNX N/A
  • DDL N/A
  • EPS
  • RGNX N/A
  • DDL 0.18
  • Revenue
  • RGNX $156,718,000.00
  • DDL $3,241,404,122.00
  • Revenue This Year
  • RGNX $327.08
  • DDL $8.80
  • Revenue Next Year
  • RGNX N/A
  • DDL $11.75
  • P/E Ratio
  • RGNX N/A
  • DDL $11.91
  • Revenue Growth
  • RGNX 80.70
  • DDL 17.62
  • 52 Week Low
  • RGNX $5.04
  • DDL $1.62
  • 52 Week High
  • RGNX $15.36
  • DDL $4.79
  • Technical
  • Relative Strength Index (RSI)
  • RGNX 48.91
  • DDL 49.58
  • Support Level
  • RGNX $8.39
  • DDL $2.01
  • Resistance Level
  • RGNX $9.27
  • DDL $2.21
  • Average True Range (ATR)
  • RGNX 0.53
  • DDL 0.07
  • MACD
  • RGNX 0.03
  • DDL 0.02
  • Stochastic Oscillator
  • RGNX 59.86
  • DDL 54.55

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

About DDL Dingdong (Cayman) Limited (each two representing three)

Dingdong (Cayman) Ltd is the fastest growing on-demand e-commerce company in China. The company directly provides users and households with fresh produce, meat and seafood, and other daily necessities through a convenient shopping experience supported by an extensive self-operated frontline fulfillment grid. It recognizes revenues from product sales of fresh groceries and other daily necessities through Dingdong Fresh APP and mini-programs and membership services.

Share on Social Networks: